Nombre del producto:3-Chloro-4-trifluoromethylpyridazine

IUPAC Name:3-chloro-4-(trifluoromethyl)pyridazine

CAS:749258-96-6
Fórmula molecular:C5H2ClF3N2
Pureza:95%+
Número de catálogo:CM362874
Peso molecular:182.53

Unidad de embalaje Stock disponible Precio($) Cantidad
CM362874-100mg in stock ǑǑŵ
CM362874-250mg in stock ǑǶŵ
CM362874-1g in stock ƿƥƛ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :749258-96-6
Fórmula molecular:C5H2ClF3N2
Punto de fusión:-
Código de sonrisas:FC(F)(F)C1=C(Cl)N=NC=C1
Densidad:
Número de catálogo:CM362874
Peso molecular:182.53
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.